InvestSMART

Optiscan Imaging Limited (ASX: OIL) - Announcements

Current share price for OIL : $0.160 0.005 (3.23%)+

ASX company news and announcements for Optiscan Imaging Limited (OIL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Optiscan Imaging Limited (OIL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Optiscan Imaging Limited (OIL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Optiscan Imaging Limited (OIL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$167 Share Purchase Plan Announcement 7 Oct 2009 9:00AM $0.110 $0.160 risen by 45.45%
$167 Response to an ASX Price Query 29 Sep 2009 9:12AM $0.120 $0.160 risen by 33.33%
$167 Preliminary Final Report 28 Aug 2009 9:57AM $0.072 $0.160 risen by 122.22%
$167 New Hoya Agreements 3 Aug 2009 9:38AM $0.070 $0.160 risen by 128.57%
$167 New Contract with Carl Zeiss 14 May 2009 9:36AM $0.046 $0.160 risen by 247.83%
$167 Optiscan Terminates 2nd Generation Agreement with Hoya 23 Mar 2009 4:48PM $0.035 $0.160 risen by 357.14%
$167 Half Yearly Report and Accounts 27 Feb 2009 5:33PM $0.040 $0.160 risen by 300%
$167 Optiscan Announces Downsizing 23 Jan 2009 2:17PM $0.063 $0.160 risen by 153.97%
$167 Optiscan commences new trial in robotic surgery 21 Nov 2008 11:12AM $0.063 $0.160 risen by 153.97%
$167 Optiscan seeking to raise capital 16 Oct 2008 3:16PM $0.100 $0.160 risen by 60%
$167 Preliminary Final Report 29 Aug 2008 9:50AM $0.185 $0.160 fallen by 13.51%
$167 Optiscan Placement Raises $3M 17 Jun 2008 11:35AM $0.245 $0.160 fallen by 34.69%
$167 Optiscan expands global coverage for FIVE 1 sales 11 Jun 2008 9:59AM $0.225 $0.160 fallen by 28.89%
$167 Endomicroscopy Takes Centre Stage at DDW 2008 2 Jun 2008 9:22AM $0.250 $0.160 fallen by 36%
$167 Multi Centre Trials in Europe Commence 30 Apr 2008 11:27AM $0.245 $0.160 fallen by 34.69%
$167 Half Yearly Report and Accounts 28 Feb 2008 4:28PM $0.200 $0.160 fallen by 20%
$167 Optiscan initiates endometriosis clinical trial 2 Oct 2007 9:21AM $0.425 $0.160 fallen by 62.35%
$167 Pentax reaffirms commitment to endomicroscope sales growth 5 Sep 2007 10:18AM $0.410 $0.160 fallen by 60.98%
$167 Preliminary Final Report 29 Aug 2007 4:12PM $0.420 $0.160 fallen by 61.90%
$167 Soft sales for Optiscan in first half year 2 Aug 2007 10:48AM $0.410 $0.160 fallen by 60.98%
$167 Pentax UK announces new training centre for 16 Jul 2007 10:11AM $0.525 $0.160 fallen by 69.52%
$167 Optiscan product sales 2006/07 $5.49M 10 Jul 2007 3:10PM $0.565 $0.160 fallen by 71.68%
$167 Successful pilot trial indicates airways applications 10 Jul 2007 9:27AM $0.565 $0.160 fallen by 71.68%
$167 Optiscan and Carl Zeiss Group Sign Collaboration Deal 3 Jul 2007 8:35AM $0.565 $0.160 fallen by 71.68%
$167 New Endomicroscope Trial at Johns Hopkins Hospital 25 Jun 2007 10:35AM $0.480 $0.160 fallen by 66.67%

576 - 600 of 633 results

Page 24 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.